Shockwave Medical Inc (SWAV)
330.63
+0.14
(+0.04%)
USD |
NASDAQ |
May 08, 16:00
330.56
-0.07
(-0.02%)
Pre-Market: 20:00
Shockwave Medical Max Drawdown (5Y): 64.92% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 64.92% |
March 31, 2024 | 64.92% |
February 29, 2024 | 64.92% |
January 31, 2024 | 64.92% |
December 31, 2023 | 64.92% |
November 30, 2023 | 64.92% |
October 31, 2023 | 64.92% |
September 30, 2023 | 64.92% |
August 31, 2023 | 64.92% |
July 31, 2023 | 64.92% |
June 30, 2023 | 64.92% |
May 31, 2023 | 64.92% |
April 30, 2023 | 64.92% |
March 31, 2023 | 64.92% |
February 28, 2023 | 64.92% |
January 31, 2023 | 64.92% |
December 31, 2022 | 64.92% |
November 30, 2022 | 64.92% |
October 31, 2022 | 64.92% |
September 30, 2022 | 64.92% |
August 31, 2022 | 64.92% |
July 31, 2022 | 64.92% |
June 30, 2022 | 64.92% |
May 31, 2022 | 64.92% |
April 30, 2022 | 64.92% |
Date | Value |
---|---|
March 31, 2022 | 64.92% |
February 28, 2022 | 64.92% |
January 31, 2022 | 64.92% |
December 31, 2021 | 64.92% |
November 30, 2021 | 64.92% |
October 31, 2021 | 64.92% |
September 30, 2021 | 64.92% |
August 31, 2021 | 64.92% |
July 31, 2021 | 64.92% |
June 30, 2021 | 64.92% |
May 31, 2021 | 64.92% |
April 30, 2021 | 64.92% |
March 31, 2021 | 64.92% |
February 28, 2021 | 64.92% |
January 31, 2021 | 64.92% |
December 31, 2020 | 64.92% |
November 30, 2020 | 64.92% |
October 31, 2020 | 64.92% |
September 30, 2020 | 64.92% |
August 31, 2020 | 64.92% |
July 31, 2020 | 64.92% |
June 30, 2020 | 64.92% |
May 31, 2020 | 64.92% |
April 30, 2020 | 64.92% |
March 31, 2020 | 64.92% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
21.97%
Minimum
May 2019
64.92%
Maximum
Mar 2020
61.49%
Average
64.92%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Boston Scientific Corp | 43.49% |
AtriCure Inc | 74.05% |
Masimo Corp | 74.70% |
Perspective Therapeutics Inc | 91.70% |
Xtant Medical Holdings Inc | 98.66% |